Domov › Akutna limfoblastna levkemija › Kalifornija › Baldwin Park
Klinične študije za Akutna limfoblastna levkemija v Baldwin Park, CA
21 študij za Akutna limfoblastna levkemija išče udeležence na lokacijah v Baldwin Park in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Vključevanje udeležencevFaza 2
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte · 4 mi stran
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Vključevanje udeležencevFaza 1/2
- Research Site, Duarte · 4 mi stran
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- City of Hope, Duarte · 4 mi stran
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
A Study of Revumenib and Mezigdomide in People With Leukemia
Vključevanje udeležencevFaza 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi stran
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Vključevanje udeležencevOpazovalna študija
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Vključevanje udeležencevFaza 3
- Ascentage Investigative Site #1062, Duarte · 4 mi stran
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Vključevanje udeležencevZgodnja faza 1
- City of Hope Medical Center, Duarte · 4 mi stran
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
Študije za Akutna limfoblastna levkemija v drugih mestih
- Houston, TX28 študij
- New York City, NY24 študij
- Seattle, WA21 študij
- Chicago, IL19 študij
- Atlanta, GA19 študij
- Memphis, TN16 študij
- Philadelphia, PA16 študij
- Washington, DC16 študij
- Boston, MA15 študij
- Los Angeles, CA14 študij
- Durham, NC13 študij
- Mountain View, CA13 študij
Druge študije v Baldwin Park
- Rak dojke45 študij
- Akutna mieločna levkemija40 študij
- Kolorektalni rak38 študij
- Nemalicelični pljučni rak36 študij
- Rak (vse vrste)33 študij
- Rak prostate30 študij
- Metastatski rak30 študij
- Mielodisplastični sindromi26 študij
- Rak jajčnikov25 študij
- Rak pljuč24 študij
- Množni mielom23 študij
- Rak želodca22 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.